Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.89 - $2.47 $4,975 - $13,809
-5,591 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$2.2 - $5.05 $12,300 - $28,234
5,591 New
5,591 $20,000
Q1 2020

May 07, 2020

SELL
$1.39 - $3.19 $2,757 - $6,328
-1,984 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$1.96 - $2.81 $1,671 - $2,396
-853 Reduced 30.07%
1,984 $5.12 Million
Q3 2019

Nov 12, 2019

BUY
$2.12 - $9.37 $6,014 - $26,582
2,837 New
2,837 $6.5 Million

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.